AtaiBeckley Inc. (ATAI) Earns Top 10 Stocks Under $5 That Could Triple

viernes, 27 de marzo de 2026, 2:56 am ET1 min de lectura
ATAI--

H.C. Wainwright is bullish on AtaiBeckley (ATAI), reaffirming its "Buy" rating and $25.00 price target. Recent Phase 2a data for BPL-003 demonstrated a therapeutic effect lasting at least 12 weeks and reinforced the company's position in the 5-MeO-DMT class. The FDA has also designated BPL-003 as a Breakthrough Therapy, supporting the overall momentum and keeping the program on schedule for launch in Q2 2026.

AtaiBeckley Inc. (ATAI) Earns Top 10 Stocks Under $5 That Could Triple

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios